Arthur M. Cohen & Associates, LLC Abb Vie Inc. Transaction History

Arthur M. Cohen & Associates, LLC

$517 Million
Q2 2024

A detailed history of Arthur M. Cohen & Associates, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Arthur M. Cohen & Associates, LLC holds 8,362 shares of ABBV stock, worth $1.65 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

8,362

Previous 8,417 0.65%

Holding current value

$1.65 Million

Previous $1.53 Million 6.4%

% of portfolio

0.28%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $8,513 - $9,941	-55 Reduced 0.65%	8,362 $1.43 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $67,124 - $76,482	-420 Reduced 4.75%	8,417 $1.53 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $23,392 - $26,344	170 Added 1.96%	8,837 $1.37 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $6,679 - $7,732	50 Added 0.58%	8,667 $1.29 Million
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $145,333 - $167,372	1,005 Added 13.2%	8,617 $1.37 Million
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $134,160 - $160,893	970 Added 14.6%	7,612 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $177,425 - $203,495	1,322 Added 24.85%	6,642 $891,000
Q2 2022 Jul 18, 2022	BUY	$137.62 - $174.96 $27,524 - $34,992	200 Added 3.91%	5,320 $815,000
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $14,517 - $18,012	-110 Reduced 2.1%	5,120 $830,000
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $27.1 Million - $30.7 Million	-254,422 Reduced 97.99%	5,230 $574,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $26.8 Million - $29.8 Million	254,422 Added 4864.67%	259,652 $599,000
Q1 2021 Apr 22, 2021	BUY	$102.3 - $112.62 $20,460 - $22,524	200 Added 3.98%	5,230 $566,000
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $31,605 - $47,917	490 Added 10.79%	5,030 $369,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $90,883 - $113,715	-1,260 Reduced 21.72%	4,540 $402,000
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $16,500 - $19,838	-262 Reduced 4.32%	5,800 $439,000
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $51,903 - $66,344	-790 Reduced 11.53%	6,062 $448,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $15,428 - $18,158	200 Added 3.01%	6,852 $552,000
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $889 - $988	10 Added 0.15%	6,652 $630,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $897 - $1,062	-10 Reduced 0.15%	6,642 $647,000
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $554,084 - $741,970	6,022 Added 955.87%	6,652 $607,000
Q4 2017 Mar 06, 2019	SELL	$89.56 - $98.21 $603,813 - $662,131	-6,742 Reduced 91.45%	630 $630,000
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $42,093 - $46,158	470 Added 6.81%	7,372 $715,000
Q3 2014 Nov 08, 2017	BUY	N/A	6,902	6,902 $614,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.

Account

Arthur M. Cohen & Associates, LLC Abb Vie Inc. Transaction History